首页 › 基金 › MILLER HOWARD INVESTMENTS INC /NY › GSK

MILLER HOWARD INVESTMENTS INC /NY 对 GSK 的持仓历史

GSK PLC · 医疗保健

MILLER HOWARD INVESTMENTS INC /NY 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC)1,174,089 股,市值约 US$56.6M,约占其申报组合的 1.54%,在其申报持仓中市值排名第 26 位。 MILLER HOWARD INVESTMENTS INC /NY 最近 8 个申报季度中有 8 个季度披露了 GSK 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)1.17M 股
申报持仓市值$56.56M
组合权重1.54%
首次申报Q4 2024
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

MILLER HOWARD INVESTMENTS INC /NY 对 GSK 的持仓演变

MILLER HOWARD INVESTMENTS INC /NY 于 Q4 2024 首次披露 GSK 持仓:690,900 股(约 US$23.4M)。 该持仓在 Q1 2026 达到峰值 1,629,351 股,市值约 US$89.9M。 在 8 次申报中,MILLER HOWARD INVESTMENTS INC /NY 2 次增持、4 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 1,174,089 股、市值约 US$56.6M,环比减持 -7,979 股。。 持仓曾出现大幅变动:Q1 2025 增持约 138% (随后一个季度股价基本持平)、Q2 2026 减持约 27% (随后一个季度股价下跌 8%)。

逐季持仓明细

季度股数金额变化
Q4 2024 690.90K $23.37M 新进
Q1 2025 1.65M $63.80M 增持
Q2 2025 1.66M $63.74M 增持
Q3 2025 1.66M $71.72M 持有
Q4 2025 1.64M $80.53M 减持
Q1 2026 1.63M $89.92M 减持
Q2 2026 1.18M $61.96M 减持
Q3 2026 1.17M $56.56M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GSK 与 13F 数据

GSK(GSK PLC)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GSK 的基金

查看 GSK 的全部基金持有人 →

常见问题

How long has MILLER HOWARD INVESTMENTS INC /NY held GSK?

MILLER HOWARD INVESTMENTS INC /NY has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is MILLER HOWARD INVESTMENTS INC /NY's current position in GSK?

As of Q3 2026, MILLER HOWARD INVESTMENTS INC /NY holds 1.17M shares of GSK (GSK PLC), valued at $56.56M, representing 1.54% of its reported portfolio and ranking #26.

Has MILLER HOWARD INVESTMENTS INC /NY been buying or selling GSK?

In the latest 13F filing (Q3 2026), MILLER HOWARD INVESTMENTS INC /NY reduced its position in GSK. The position peaked in Q1 2026 at 1.63M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.